Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.033 | 0.5 |
Loa Loa (eye worm) | glutaminase | 0.0275 | 0.9873 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0063 | 0.1128 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0157 | 0.5002 | 1 |
Mycobacterium ulcerans | putative oxalyl-CoA decarboxylase | 0.011 | 0.3066 | 0.3105 |
Schistosoma mansoni | glutaminase | 0.0275 | 0.9873 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.033 | 1 |
Mycobacterium ulcerans | acetolactate synthase 1 catalytic subunit | 0.011 | 0.3066 | 0.3105 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0157 | 0.5002 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.033 | 0.0334 |
Mycobacterium ulcerans | pyruvate or indole-3-pyruvate decarboxylase Pdc | 0.0063 | 0.1128 | 0.1143 |
Loa Loa (eye worm) | glutaminase 2 | 0.0275 | 0.9873 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0063 | 0.1128 | 0.5 |
Loa Loa (eye worm) | thiamine pyrophosphate enzyme | 0.0063 | 0.1133 | 0.0841 |
Mycobacterium ulcerans | glutaminase | 0.0275 | 0.9873 | 1 |
Mycobacterium leprae | PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) | 0.011 | 0.3066 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0157 | 0.5002 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.5002 | 0.4896 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.033 | 0.0334 |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.3487 | 0.3308 |
Mycobacterium tuberculosis | Acetolactate synthase (large subunit) IlvB1 (acetohydroxy-acid synthase) | 0.0047 | 0.0474 | 0.0148 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.033 | 0.2927 |
Mycobacterium ulcerans | hypothetical protein | 0.011 | 0.3066 | 0.3105 |
Schistosoma mansoni | acetolactate synthase | 0.0094 | 0.2407 | 0.2176 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.3487 | 0.3308 |
Mycobacterium ulcerans | acetolactate synthase | 0.0063 | 0.1128 | 0.1143 |
Mycobacterium tuberculosis | Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) | 0.011 | 0.3066 | 0.2829 |
Leishmania major | putative pyruvate/indole-pyruvate carboxylase, putative | 0.0063 | 0.1128 | 1 |
Onchocerca volvulus | 0.0043 | 0.033 | 0.5 | |
Onchocerca volvulus | 0.0043 | 0.033 | 0.5 | |
Mycobacterium ulcerans | acetolactate synthase large subunit IlvB | 0.0063 | 0.1128 | 0.1143 |
Trichomonas vaginalis | glutaminase, putative | 0.0275 | 0.9873 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.3487 | 0.3308 |
Mycobacterium leprae | Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) | 0.011 | 0.3066 | 1 |
Brugia malayi | Muscleblind-like protein | 0.0157 | 0.5002 | 0.4896 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.033 | 0.0334 |
Mycobacterium tuberculosis | Probable oxalyl-CoA decarboxylase OxcA | 0.011 | 0.3066 | 0.2829 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.033 | 0.0334 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.5002 | 0.4896 |
Loa Loa (eye worm) | ILVBL protein | 0.0066 | 0.1279 | 0.0994 |
Schistosoma mansoni | acetolactate synthase | 0.0094 | 0.2407 | 0.2176 |
Onchocerca volvulus | 0.0043 | 0.033 | 0.5 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.033 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.0275 | 0.9873 | 1 |
Brugia malayi | Thiamine pyrophosphate enzyme, central domain containing protein | 0.011 | 0.3066 | 0.2867 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.033 | 1 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.033 | 0.0334 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.2944 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.